Mengenal Bio Saliva, Tes PCR Covid-19 Lewat Kumur Buatan Bio Farma

Aditya Fahmi Nurwahid

Editor:

  • PT Bio Farma kini mempersiapkan inovasi alat tes Covid-19 menggunakan metode kumur.
  • Sampel kumur nantinya dikombinasikan dengan alat PCR (polymerase chain reaction) sebagai alternatif tes swab PCR nasofaring-orofaring.
  • Tahap pengembangan sudah melibatkan 400 sampel dan riset validasi selama tujuh bulan.

SKOR.id - Satu lagi metode tes Covid-19 akan diluncurkan, yakni tes PCR menggunakan metode kumur yang dinamakan Bio Saliva.

Bio Saliva merupakan inovasi tes yang kini dikembangkan perusahaan farmasi dalam negeri, PT Bio Farma, dan perusahaan rintisan bioteknologi Nusantics.

Metode kumur (gargling) menjadi metode yang digunakan untuk mengambil sampel, lalu diperiksa menggunakan alat PCR (polymerase chain reaction).

 

Jika telah melewati tahap validasi dan riset, tes kumur PCR ini akan menjadi alternatif dari swab nasofaring-orofaringyang kini sudah ada.

Dikutip dari Pikiran Rakyat, pengembangan produk Bio Saliva ini sudah melibatkan 400 sampel pasien rawat jalan, maupun rawat inap dan riset validasi selama 7 bulan.

Uji validasi telah selesai dilakukan bersama-sama dengan Fakultas Kedokteran Universitas Diponegoro, Rumah Sakit Nasional Diponegoro (RSND) dan Rumah Sakit Dokter Kariadi (RSDK).

Akurasi Bio Saliva

Dalam keterangan terbarunya, Bio Saliva dapat mendeteksi hingga angka CT 40 dan memiliki performance yang sangat baik untuk CT <35 dengan sensitivitas hingga 93,57 persen.

Angka tersebut menunjukkan bahwa metode PCR kumur bisa menjadi alternatif selain gold standard PCR Swab nasofaring-orofaring yang memiliki sensitifitas hingga 95 persen.

Metode kumur bahkan diprediksi akan membuat tracing dan tingkat tes di Indonesia makin naik karena lebih nyaman dibanding swab nasofaring-orofaring.

Dalam rilisnya, Bio Saliva akan cocok untuk screening rutin atau tes masal, terutama untuk para pekerja pabrik/kawasan industri, gedung perkantoran, permukiman dan sekolah.

PCR kumur ala Bio Saliva diprediksi akan mempermudah pemantauan dan deteksi awal, juga menambah kapasitas dan efisiensi lab klinis mitra BioSaliva.

Selain itu, PT Bio Farma juga terus mengembangkan kebutuhan akan alat uji yang nyaman dan akurat.

Penggunaan Bio Saliva, bersama dengan m-BioCov-19, dapat mendeteksi mutasi B 117 (Alpha), B 1.351 (Beta), P.1 (Gamma), B 1.617.2 (Delta), B 1.617.1 (Kappa), B 1.525 (Eta), B 1.526 (Iota), B 1.466.2 (varian Indonesia), B 1.427/29 (Epsilon), dan C.37 (Lambda).

Sampai saat ini belum ada produk alat uji Covid-19 di Indonesia yang dapat mendeteksi 10 (sepuluh) varian mutasi Covid-19.

Ikuti juga InstagramFacebook, dan Twitter dari Skor Indonesia.

Berita Lainnya:

Belajar dari Rio 2016, The Daddies Tak Mau Terlalu Ambisius di Olimpiade Tokyo

Jelang Olimpiade Tokyo, Jepang Tetapkan Indonesia sebagai Negara dengan Risiko Tinggi Covid-19 

Source: Pikiran Rakyat

RELATED STORIES

5 Manfaat Susu Kedelai untuk Kesehatan, Bisa Mencegah Kanker!

5 Manfaat Susu Kedelai untuk Kesehatan, Bisa Mencegah Kanker!

Susu kedelai sering menjadi pilihan alternatif untuk seseorang yang intoleransi laktosa terhadap susu sapi.

Skor co creators network
RIGHT_ARROW
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
PLAY_ICON
RIGHT_ARROW

THE LATEST

FFWS Global Finals 2025. (Grafis: Deni Sulaeman/Skor.id)

Esports

JKT48 Bakal Jadi Pembuka Grand Final FFWS Global Finals 2025 di Indonesia Arena

Kabar tersebut disampaikan oleh Garena Free Fire lewat akun Instagram Free Fire Esports Indonesia.

Gangga Basudewa | 03 Nov, 11:45

Timnas U-17 Indonesia (Indonesia U-17) vs Zambia U-17 di Piala Dunia U-17 2025. (Grafis: Deni Sulaeman/Skor.id)

Timnas Indonesia

Prediksi dan Link Live Streaming Timnas U-17 Indonesia vs Zambia di Piala Dunia U-17 2025

Laga Timnas U-17 Indonesia vs Zambia akan digelar di Aspire Zone, Qatar, Selasa (4/11/2025) malam WIB.

Rais Adnan | 03 Nov, 11:37

Advance to Swiss Stage Clash Squad FFWS Global Finals 2025 Jakarta. (Garena)

Esports

Delapan Tim Siap Tampil di Swiss Stage FFWS Global Finals 2025 Jakarta Mode Clash Squad

RRQ Kazu akan menjadi satu-satunya wakil Indonesia di turnamen internasional mode Clash Squad tahun ini.

Gangga Basudewa | 03 Nov, 11:18

RRQ(Jovi Arnanda/Skor.id)

Esports

RRQ Jadi Wakil Keempat Indonesia di KIC 2025

RRQ lolos bersama tiga tim lain yakni Bigetron Esports, Kagendra, dan Vesakha Esports.

Gangga Basudewa | 03 Nov, 10:47

Pemain Timnas U-17 Indonesia, Fadly Alberto. (Foto: Dok. Timnas Indonesia/Grafis: Deni Sulaeman/Skor.id)

Timnas Indonesia

FIFA Soroti Kualitas Penyerang Timnas U-17 Indonesia Fadly Alberto

FIFA menilai Fadly Alberto menjadi salah satu talenta dari Asia yang bakal bersinar di Piala Dunia U-17 2025.

Rais Adnan | 03 Nov, 08:39

Kompetisi sepak bola kasta kedua di Indonesia atau identitas baru dari Liga 2 musim terbaru, Championship 2025-2026. (Deni Sulaeman/Skor.id)

Liga 2

Championship 2025-2026: Jadwal, Hasil dan Klasemen Lengkap

Jadwal, hasil, dan klasemen Liga 2 atau Championship 2025-2026 yang terus diperbarui seiring bergulirnya kompetisi.

Taufani Rahmanda | 03 Nov, 08:11

Timnas Indonesia

Timnas Indonesia

PSSI Cari Pelatih Anyar Timnas Indonesia untuk Jangka Panjang

Vivin Cahyani Sungkono mengungkapkan PSSI kini lebih dulu fokus untuk mendukung Timnas U-23 Indonesia pada SEA Games 2025.

Rais Adnan | 03 Nov, 07:58

FFWS Global Finals 2025 di Jakarta. (Garena)

Esports

Rekap Hasil FFWS Global Finals 2025 Pekan Pertama, RRQ di Papan Atas

Beda RRQ beda pula nasib dari EVOS Divine yang harus berjuang lebih keras lagi setelah hanya menempati peringkat ke-13.

Gangga Basudewa | 03 Nov, 06:37

M7 World Championship, Jakarta. (Moonton)

Esports

M7 World Championship Bakal Gunakan Dua Venue Ini

MPL Arena dan Tenis Indoor Senayan akan menjadi venue M7 World Championship, Jakarta.

Gangga Basudewa | 03 Nov, 05:42

Liga Italia (Serie A) musim 2025-2026. (Grafis: Deni Sulaeman/Skor.id).

Liga Italia

Liga Italia 2025-2026: Jadwal, Hasil dan Klasemen Lengkap

Jadwal, hasil, dan klasemen lengkap Liga Italia 2025-2026 yang diperbarui seiring berjalannya kompetisi.

Pradipta Indra Kumara | 03 Nov, 03:43

Load More Articles